Extraordinary General Meeting

July 26, 2018

The shareholders of Wilson Therapeutics AB (publ) (the “Company”), reg. no 556893-0357, are hereby summoned to an extraordinary general meeting, to be held on Thursday 26 July 2018, at 4:00 p.m. (CET) at Advokatfirman Cederquist’s premises at Hovslagargatan 3 in Stockholm, Sweden. Registration opens at 3:30 p.m. (CET).

Documents